» Articles » PMID: 33351674

Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience

Overview
Journal JCO Oncol Pract
Specialty Oncology
Date 2020 Dec 22
PMID 33351674
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The COVID-19 outbreak rapidly became a public health emergency and led to radical changes in patient management. From the start of the pandemic, we used electronic medical record-assisted telephone follow-up (E-TFU) of cancer survivors (CS) to minimize hospital exposure. The aim of this prospective study was to assess how breast cancer survivors (bCSs) perceived E-TFU.

Materials And Methods: A 15-item survey was e-mailed to bCSs who had been managed with E-TFU. The responses were measured using Likert-like scales and were correlated with the main characteristics of the bCS using Pearson's test.

Results: One hundred thirty-seven of 343 bCSs (40%) completed the survey between March 9 and June 2, 2020. Their median age was 59 years. Although 80.3% of bCSs were satisfied with E-TFU, only 43.8% would like to have E-TFU in the future. A low educational level was correlated with higher COVID-19-related anxiety ( = .025). An older age ( = .002) and a low educational level ( < .0001) were correlated with the need to be accompanied to reach the hospital. A personal history of second cancer was inversely correlated with understanding medical advice ( = .015) and the expectation of feeling relief after a follow-up visit ( = .0027). Furthermore, pandemic phase II was correlated with satisfaction with E-TFU ( = .010).

Conclusion: E-TFU was an important means of avoiding hospital contacts during the COVID-19 pandemic, and the majority of bCSs in the survey were satisfied with this procedure. Further studies are needed to investigate the implementation of telemedicine even outside an emergency situation.

Citing Articles

Virtual follow-up care among breast and prostate cancer patients during and beyond the COVID-19 pandemic: Association with distress.

Bender J, Scruton S, Wong G, Abdelmutti N, Berlin A, Easley J Cancer Med. 2024; 13(4):e6948.

PMID: 38466233 PMC: 10926960. DOI: 10.1002/cam4.6948.


Telehealth in breast cancer following the coronavirus disease 2019 pandemic.

Zeghondy J, Rassy E, Lapidari P, Eid R, Pistilli B Explor Target Antitumor Ther. 2024; 4(6):1249-1259.

PMID: 38213534 PMC: 10776597. DOI: 10.37349/etat.2023.00195.


Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement.

Beretta G, Casolino R, Corsi D, Perrone F, Di Maio M, Cinieri S ESMO Open. 2022; 7(4):100538.

PMID: 35921761 PMC: 9222406. DOI: 10.1016/j.esmoop.2022.100538.


Counting the social, psychological, and economic costs of COVID-19 for cancer patients.

Kirby A, Drummond F, Lawlor A, Murphy A Support Care Cancer. 2022; 30(11):8705-8731.

PMID: 35690662 PMC: 9188420. DOI: 10.1007/s00520-022-07178-0.


Mitigating the Impact of the COVID-19 Pandemic on Adult Cancer Patients through Telehealth Adoption: A Systematic Review.

Murphy A, Kirby A, Lawlor A, Drummond F, Heavin C Sensors (Basel). 2022; 22(9).

PMID: 35591287 PMC: 9105995. DOI: 10.3390/s22093598.